TrialEuropean journal of haematology2012

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study.

Martin Hjorth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.